Attention Deficit Hyperactivity Disorder and Inflammation: Inflammasome Complexes
PDF
Cite
Share
Request
REVIEW
P: 186-191
November 2024

Attention Deficit Hyperactivity Disorder and Inflammation: Inflammasome Complexes

Turk J Child Adolesc Ment Health 2024;31(3):186-191
No information available.
No information available
Received Date: 18.09.2022
Accepted Date: 15.03.2024
Online Date: 25.11.2024
Publish Date: 25.11.2024
PDF
Cite
Share
Request

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents that is characterized with attention deficit, hyperactivity, and impulsiveness. Emerging evidence suggests that neuroinflammation mediated by inflammasome activation can influence brain development and potentially precipitate neurodevelopmental disorders. Inflammasomes are intracellular multimeric protein complexes that are intimately involved in the inflammatory response. Although epigenetic alterations associated with neuroinflammation and inflammasome have been postulated to contribute to ADHD’s etiology, extant research in this domain remains scant. Notably, inflammasome are being considered as both potential biomarkers for ADHD diagnosis and therapeutic targets, with inflammasome inhibition being a promising treatment avenue for patients with ADHD. This review aimed to elucidate the relationship between neuroinflammation, inflammasome, and ADHD etiology.

Keywords:
Attention deficit hyperactivity disorder, inflammasome, neuroinflammation, epigenetics